Issue navigation
Volume 24, Issue 7, July 2022
Reviews
Diagnosis and management of arrhythmias in pregnancy
EP Europace, Volume 24, Issue 7, July 2022, Pages 1041–1051, https://doi.org/10.1093/europace/euab297
Impact of sodium-glucose co-transporter inhibitors on cardiac autonomic function and mortality: no time to die
EP Europace, Volume 24, Issue 7, July 2022, Pages 1052–1057, https://doi.org/10.1093/europace/euab321
Clinical Research
Atrial Fibrillation
Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke
EP Europace, Volume 24, Issue 7, July 2022, Pages 1058–1064, https://doi.org/10.1093/europace/euab324
Impact of oral anticoagulation on the association between frailty and clinical outcomes in people with atrial fibrillation: nationwide primary care records on treatment analysis
EP Europace, Volume 24, Issue 7, July 2022, Pages 1065–1075, https://doi.org/10.1093/europace/euac022
Digoxin use and clinical outcomes in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
EP Europace, Volume 24, Issue 7, July 2022, Pages 1076–1083, https://doi.org/10.1093/europace/euab319
Ablation for Atrial Fibrillation
First experience with pulsed field ablation as routine treatment for paroxysmal atrial fibrillation
EP Europace, Volume 24, Issue 7, July 2022, Pages 1084–1092, https://doi.org/10.1093/europace/euac041
Does isolation of the left atrial posterior wall using cryoballoon ablation improve clinical outcomes in patients with persistent atrial fibrillation? A prospective randomized controlled trial
EP Europace, Volume 24, Issue 7, July 2022, Pages 1093–1101, https://doi.org/10.1093/europace/euac005
Comparison of various late gadolinium enhancement magnetic resonance imaging methods with high-definition voltage and activation mapping for detection of atrial cardiomyopathy
EP Europace, Volume 24, Issue 7, July 2022, Pages 1102–1111, https://doi.org/10.1093/europace/euac010
Ventricular Tachycardia: Mapping and Ablation
Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial
EP Europace, Volume 24, Issue 7, July 2022, Pages 1112–1118, https://doi.org/10.1093/europace/euab328
Pacing and Cardiac Resynchronization Therapy
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker
EP Europace, Volume 24, Issue 7, July 2022, Pages 1119–1126, https://doi.org/10.1093/europace/euab315
Long-term clinical impact of permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis
EP Europace, Volume 24, Issue 7, July 2022, Pages 1127–1136, https://doi.org/10.1093/europace/euac008
Clinical Electrophysiolog
Left ventricular shape predicts arrhythmic risk in fibrotic dilated cardiomyopathy
EP Europace, Volume 24, Issue 7, July 2022, Pages 1137–1147, https://doi.org/10.1093/europace/euab306
Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation
EP Europace, Volume 24, Issue 7, July 2022, Pages 1148–1155, https://doi.org/10.1093/europace/euab282
Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse
EP Europace, Volume 24, Issue 7, July 2022, Pages 1156–1163, https://doi.org/10.1093/europace/euac017
Syncope
Theophylline in patients with syncope without prodrome, normal heart, and normal electrocardiogram: a propensity-score matched study verified by implantable cardiac monitor
EP Europace, Volume 24, Issue 7, July 2022, Pages 1164–1170, https://doi.org/10.1093/europace/euab300
Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis
EP Europace, Volume 24, Issue 7, July 2022, Pages 1171–1178, https://doi.org/10.1093/europace/euab323
EP Case Express
Cardioneuroablation of the right anterior ganglionated plexus in symptomatic sinus bradycardia after extensive weight loss
EP Europace, Volume 24, Issue 7, July 2022, Page 1178, https://doi.org/10.1093/europace/euab331
EHRA Survey
Management of conduction disorders after transcatheter aortic valve implantation: results of the EHRA survey
EP Europace, Volume 24, Issue 7, July 2022, Pages 1179–1185, https://doi.org/10.1093/europace/euac027
Technical Issues
Hybrid machine learning to localize atrial flutter substrates using the surface 12-lead electrocardiogram
EP Europace, Volume 24, Issue 7, July 2022, Pages 1186–1194, https://doi.org/10.1093/europace/euab322
Letters to the Editor
CHA2DS2-VASc is no longer enough
EP Europace, Volume 24, Issue 7, July 2022, Page 1195, https://doi.org/10.1093/europace/euac018
CHA2DS2-VASc score is no longer enough—Authors’ reply
EP Europace, Volume 24, Issue 7, July 2022, Page 1195, https://doi.org/10.1093/europace/euac019
One of the clinical dilemmas: the longer the more indicated?
EP Europace, Volume 24, Issue 7, July 2022, Page 1196, https://doi.org/10.1093/europace/euac064
A clinical dilemma: the longer the higher the risk?—Authors’ reply
EP Europace, Volume 24, Issue 7, July 2022, Pages 1196–1197, https://doi.org/10.1093/europace/euac065
Corrigendum
Corrigendum to: Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey
EP Europace, Volume 24, Issue 7, July 2022, Page 1185, https://doi.org/10.1093/europace/euac051
